5-amino-1mq peptide therapy Guide: Reported Use, Reconstitution & Evidence 5-Amino-1MQ Peptide Dosing Guide: Oral

It is specially indicated for the treatment of anorexia and liver disorders associated with fatty degeneration of liver, sluggish liver, debility and general weakness, blood protozoan diseases, hepatitis and jaundice, reduced feed intake, stress etc

A caregiver, friend, or family member can assist with injections into this muscle

In early studies, this leads to better energy utilization and potentially more significant fat loss than whats been documented with AOD9604 (review)

Key findings from SURMOUNT-1 include a mean weight loss of 15.0% at the 5mg dose, 19.5% at the 10mg dose, and 20.9% at the 15mg dose over 72 weeks

Side Effects and the Copper Uglies Explained GHK-Cu has a strong safety profile in topical research, but a small subset of users experience a transient phase known as the copper uglies. A 2023 clinical safety review covering 12 studies and 512 participants reported that the most common side effects of topical GHK-Cu were transient and mild